BRISTOL-MYERS SQUIBB CO. v. BEN VENUE LABS., INC.

No. 00-1304.

246 F.3d 1368 (2001)

BRISTOL-MYERS SQUIBB COMPANY, Plaintiff-Appellant, v. BEN VENUE LABORATORIES, INC., Bedford Laboratories, and Boehringer Ingelheim Corporation, Defendants-Appellees, and Immunex Corporation (ANDA now owned by Baker Norton Pharmaceuticals, Inc.), Ivax Corporation, and Zenith Goldline Pharmaceuticals, Inc., Defendants-Appellees, and Marsam Pharmaceuticals, Inc. and Schein Pharmaceutical, Inc., Defendants-Appellees, and Mylan Pharmaceuticals, Inc., Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Rehearing and Rehearing Denied June 13, 2001.


Attorney(s) appearing for the Case

Robert L. Baechtold, Fitzpatrick, Cella, Harper & Scinto, of New York, NY, argued for plaintiff-appellant. With him on the brief were Nicholas M. Cannella, Bruce C. Haas, Jennifer A. Reda, and F. Christopher Mizzo. Of counsel on the brief were Evan R. Chesler, and Richard J. Stark, Cravath, Swaine & Moore, of New York, NY. Also of counsel on the brief was William J. O'Shaughnessy, McCarter & English, of Newark, NJ.

Martin B. Pavane, Cohen, Pontani, Lieberman & Pavane, of New York, NY, argued for defendants-appellees Ben Venue Laboratories, Inc. et al. With him on the brief were William A. Alper, and Mindy H. Chettih. Of counsel on the brief was Robert P. Raymond, Boehringer Ingelheim Corporation, of Ridgefield, CT. Of counsel were Alfred H. Hemingway, Jr., and Yunling Ren.

William L. Mentlik, Lerner, David, Littenberg, Krumholz & Mentlik, LLP, of Westfield, NJ, argued for defendants-appellees Immunex Corporation, et al. With him on the brief were Arnold H. Krumholz, Roy H. Wepner, and Michael H. Teschner. Of counsel on the brief was Jay B. Shapiro, Stearns Weaver Miller Weissler Alhadeff & Sitterson, P.A., of Miami, FL. Also of counsel on the brief were Gerson A. Zweifach, and Sharon L. Davis, Williams & Connolly LLP, of Washington, DC.

E. Anthony Figg, Rothwell, Figg, Ernst & Manbeck P.C., of Washington, DC, for defendant-appellee Mylan Pharmaceuticals, Inc. With him on the brief were Steven Lieberman, and Glenn E. Karta. Of counsel on the brief was Charles Guttman, Proskauer Rose LLP, of New York, NY, for defendant-appellee Marsam Pharmaceutical, Inc., et al. Of counsel was Frank Holahan, Harwood & Lloyd, LLC, of Hackensack, NJ.

Before LOURIE, GAJARSA, and DYK, Circuit Judges.


Rehearing and Rehearing En Banc Denied June 13, 2001.

LOURIE, Circuit Judge.

Bristol-Myers Squibb Company appeals from the decision of the United States District Court for the District of New Jersey granting the motion by Ben Venue Laboratories, Inc., Bedford Laboratories, Boehringer Ingelheim Corporation, Immunex Corporation, IVAX Corporation, Zenith Goldline Pharmaceuticals, Inc., Marsam Pharmaceuticals, Inc., Schein Pharmaceutical, Inc., and Mylan Pharmaceuticals...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases